In the first clinical study, 39 healthy subjects (53 +/- 11 years old;20 males and 19 females) had a total daily NaCl intake of 50 mmol (low-salt) and 150 mmol (high-salt) for 4 weeks each, in random order. Ambulatory blood pressure (ABP) and marinobufagenin (MBG) in plasma and urine were measured at baseline (unstandardized salt intake) and after high- and low-salt intake. At baseline, plasma MBG (P-MBG) was related to 24-hour systolic (r= 0.43, P=0.007) and diastolic (r=0.32, P=0.047) BP. Interestingly, gender-specific analyses revealed that these relationships were significant in males only. Compared to low-salt, high-salt diet increased P-MBG (P=0.029), mainly driven by results in men. Male P-MBG responders vs. non-responders (above vs. below median of high-salt induced P-MBG increase) had markedly enhanced systolic (10.4 +/- 6.4 vs. 0.0 +/- 6.0 mmHg;P=0.003) and diastolic (6.7 +/- 5.0 vs. -0.6 +/- 3.6 mm Hg;P=0.001) BP salt sensitivity. We conclude that in males MBG increases with 24-hour ABP, and similar to Dahl-S, 4-weeks of high-salt induced MBG response is accompanied by marked increase in salt sensitivity. However, these patterns seem to be gender specific and are not observed in human females. In the second experiment we studied three groups of male Dahl-S (n=6 each): rats on a low salt (0.1% NaCl) diet (LS);rats on a high salt (8% NaCl) diet for 7 weeks (HS);and rats on a high salt diet for 7 weeks, followed by 3E9 anti-MBG mAb treatment for 1 week (HSAB). SBP, ECHO parameters, creatinine clearance, levels of MBG, weights of aortae, left ventricles (LV) and kidneys were assessed. In HS vs. LS, SBP increased by 74 mm Hg (P<0.01), plasma MBG doubled (P<0.05), renal MBG excretion increased 6-fold (P<0.01), tissue weights increased (LV: 2.37 +/- 0.05 vs. 1.62 +/- 0.04 g/kg BW, P<0.01;aorta: 4.44 +/- 0.17 vs. 3.01 +/- 0.06 mg/mm per kg BW, P<0.01;kidneys: 11.29 +/- 0.2 vs. 8.37 +/- 0.11 g/kg BW, P<0.01), LV fractional shortening decreased (46 +/- 1.2% vs. 58 +/- 2%, P<0.01), and creatinine clearance decreased (1.94 +/- 0.25 vs. 2.61 +/- 0.18 mg/mL, P<0.01). A single intra-peritoneal administration of anti-MBG monoclonal antibody to hypertensive DS (HSAB group) reduced SBP by 35 mm Hg (P<0.01) after just 1 week, markedly reduced weights of LV (2.03 +/- 0.08 g/kg BW, P<0.01), aortae (3.72 +/- 0.06 mg/mm per kg BW, P<0.05), and kidneys (10.7 +/- 0.29 g/kg BW, P<0.05), increased LV fractional shortening (52 +/- 1%, P<0.05) vs. HS group, and restored the creatinine clearance to control (LS) levels (2.82 +/- 0.22 mg/mL, P<0.05). In hypertensive DS there was a tissue-specific pattern of up-regulation of expression of genes, implicated in TGF-beta-signaling (LV: TGF-beta1, TGF-beta2, MAPK3, CTGF, SMADs, collagen-1;aorta: TGF-beta1, TGF-beta2, TGF-beta3, PDGF, fibronectin, SNAIL1, collagens;kidneys TGF-beta1, ITGB1, collagen-1), that was down-regulated following immunoneutralization of MBG. Thus, immunoneutralization of heightened MBG levels in Dahl-S normalized renal function and produced an anti-hypertensive and an anti-remodeling effect associated with down-regulation of genes implicated in TGF-beta-induced fibrosis initiated by MBG in salt-sensitive hypertension.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Investigator-Initiated Intramural Research Projects (ZIA)
Project #
1ZIAAG000609-22
Application #
8931554
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
22
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Aging
Department
Type
DUNS #
City
State
Country
Zip Code
Chirinos, Julio A; Sardana, Mayank; Oldland, Garrett et al. (2018) Association of arginine vasopressin with low atrial natriuretic peptide levels, left ventricular remodelling, and outcomes in adults with and without heart failure. ESC Heart Fail 5:911-919
Strauss, Michél; Smith, Wayne; Kruger, Ruan et al. (2018) Marinobufagenin and left ventricular mass in young adults: The African-PREDICT study. Eur J Prev Cardiol 25:1587-1595
Chirinos, Julio A; Sardana, Mayank; Syed, Amer Ahmed et al. (2018) Aldosterone, inactive matrix gla-protein, and large artery stiffness in hypertension. J Am Soc Hypertens 12:681-689
Strauss, Michél; Smith, Wayne; Wei, Wen et al. (2018) Marinobufagenin is related to elevated central and 24-h systolic blood pressures in young black women: the African-PREDICT Study. Hypertens Res 41:183-192
AlGhatrif, Majd; Wang, Mingyi; Fedorova, Olga V et al. (2017) The Pressure of Aging. Med Clin North Am 101:81-101
Gable, Marjorie E; Ellis, Linda; Fedorova, Olga V et al. (2017) Comparison of Digitalis Sensitivities of Na(+)/K(+)-ATPases from Human and Pig Kidneys. ACS Omega 2:3610-3615
Fedorova, Olga V; Zernetkina, Valentina I; Shilova, Victoria Y et al. (2015) Synthesis of an Endogenous Steroidal Na Pump Inhibitor Marinobufagenin, Implicated in Human Cardiovascular Diseases, Is Initiated by CYP27A1 via Bile Acid Pathway. Circ Cardiovasc Genet 8:736-45
Fedorova, Olga V; Lakatta, Edward G; Bagrov, Alexei Y et al. (2015) Plasma level of the endogenous sodium pump ligand marinobufagenin is related to the salt-sensitivity in men. J Hypertens 33:534-41; discussion 541
Kennedy, David J; Shrestha, Kevin; Sheehey, Brendan et al. (2015) Elevated Plasma Marinobufagenin, An Endogenous Cardiotonic Steroid, Is Associated With Right Ventricular Dysfunction and Nitrative Stress in Heart Failure. Circ Heart Fail 8:1068-76
Fedorova, Olga V; Emelianov, Igor V; Bagrov, Konstantin A et al. (2015) Marinobufagenin-induced vascular fibrosis is a likely target for mineralocorticoid antagonists. J Hypertens 33:1602-10

Showing the most recent 10 out of 23 publications